The global Glucose Monitoring Devices market size in 2023 is 12734.5 million US dollars, and it is expected to be 22483.8 million US dollars by 2030, with a compound annual growth rate of 8.46% expected in 2024-2030.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Glucose Monitoring Devices market include DiaMonTech AG (Germany), Abbott (U.S.), GlySens Incorporated (U.S.), Novo Nordisk A/S (Denmark), and Nemaura (U.S.). The share of the top 3 players in the Glucose Monitoring Devices market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Glucose Monitoring Devices market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Self-Monitoring Blood Glucose Devices accounted for XX% of Glucose Monitoring Devices market in 2023. Continuous Glucose Monitoring Devices share of XX%.
Hospital accounted for XX% of the Glucose Monitoring Devices market in 2023. Clinics accounts for XX%.

The cumulative impact of COVID-19, Russia-Ukraine conflict, and high inflation is expected to have a significant long-term impact on the global Glucose Monitoring Devices markets. Ongoing research considers changes in consumer behavior, supply chain disruptions, and government intervention caused by the pandemic. Likewise, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine conflict and its potential impact on the supply-demand balance, pressure on pricing variables, and import, export, and trade. In addition, the report discusses the impact of high inflation on the global economy and details fiscal policies to measure and reduce its impact on demand, supply, cash flows, and currency exchange.

Market Statistics:
Reports provide market sizes and forecasts for multiple major currencies (USD, EUR, JPY, GBP, CNY, etc.); multi-currency support helps organizational leaders make informed decisions. This report takes 2019-2021 as the historical year, 2023 as the base year, 2024 as the semi-forecast year, and 2024-2030 as the full forecast year.

Market Share Analysis:
Market share analysis provides deep insights into the current status of vendors in a particular market space. By comparing suppliers' contributions to total revenue, customer base, and other key metrics, we can give companies a better understanding of their performance and the challenges they face as they compete for market share. The analysis also sheds light on the competitiveness of any given sector in terms of accumulation, diversification of strengths, and consolidation characteristics during the base year studied.

The report provides insights on the following metrics:
Market Penetration: Provides comprehensive information on the market offered by key players
Market Diversification: Provides detailed information on new product launches, greenfield regions, recent developments and investments
Market Trends: A Big Picture of the Cumulative Impact of COVID-19, Russia-Ukraine Conflict, and High Inflation
Competitive assessment and intelligence: Provides an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape and manufacturing capabilities of leading players
Product Development & Innovation: Provides intelligent insights into future technologies, R&D activities, and breakthrough product developments
Market Segmentation: Segment by Type, Application, and Region to provide detailed insights into market information.

Highlights-Regions

North America
Europe
China
Japan
Korea
Southeast Asia
India
South America
Middle East & Africa

Player list
DiaMonTech AG (Germany)
Abbott (U.S.)
GlySens Incorporated (U.S.)
Novo Nordisk A/S (Denmark)
Nemaura (U.S.)
PHC Holdings Corporation (Japan)
TaiDoc Technology Corporation (Taiwan)
AgaMatrix (U.S.)
Dexcom, Inc. (U.S.).
ACON Laboratories, Inc.(U.S.).
Ascensia Diabetes Care Holdings AG (Switzerland)
Bayer AG (Germany)
F. Hoffmann-La Roche Ltd (Switzerland)
Insulet Corporation (U.S.)
Ypsomed AG (Switzerland)
GlySens Incorporated (U.S.)

Types list
Self-Monitoring Blood Glucose Devices
Continuous Glucose Monitoring Devices

Application list
Hospital
Clinics
Diagnostic Centers
Home Healthcare
Others